Lysophosphatidic acid (LPA)-induced vasodilator-stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cells

Molecular Oncology

Volumn 2, Issue 1, 2008, Pages 54-69

  Hasegawa, Yutaka ^a   Murph, Mandi ^a   Yu, Shuangxing ^a   Tigyi, Gabor ^b   Mills, Gordon B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Lamellipodia; Lysophosphatidic acid (LPA); Protein kinase A (PKA); Vasodilator stimulated phosphoprotein (VASP)

Indexed keywords

ACTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR LPA1; LYSOPHOSPHATIDIC ACID RECEPTOR LPA2; LYSOPHOSPHATIDIC ACID RECEPTOR LPA3; LYSOPHOSPHATIDIC ACID RECEPTOR LPA4; SERINE; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER SURVIVAL; CELL LINEAGE; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME INHIBITION; HUMAN; HUMAN CELL; LAMELLIPODIUM; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 43649108750     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2008.03.009     Document Type: Article

References (57)

1. S. An T. Bleu O.G. Hallmark E.J. Goetzl Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid The Journal of Biological Chemistry 273 14 1998 7906 7910
2. S. An C. Tsai E.J. Goetzl Cloning, sequencing and tissue distribution of two related G protein-coupled receptor candidates expressed prominently in human lung tissue FEBS Letters 375 1–2 1995 121 124
3. D.L. Baker Y. Fujiwara K.R. Pigg R. Tsukahara S. Kobayashi H. Murofushi A. Uchiyama K. Murakami-Murofushi E. Koh R.W. Bandle H.S. Byun R. Bittman D. Fan M. Murph G.B. Mills G. Tigyi Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis The Journal of Biological Chemistry 281 32 2006 22786 22793
4. K. Bandoh J. Aoki A. Taira M. Tsujimoto H. Arai K. Inoue Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure–activity relationship of cloned LPA receptors FEBS Letters 478 1–2 2000 159 165
5. M. Barzik T.I. Kotova H.N. Higgs L. Hazelwood D. Hanein F.B. Gertler D.A. Schafer Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins The Journal of Biological Chemistry 280 31 2005 28653 28662
6. D. Bian C. Mahanivong J. Yu S.M. Frisch Z.K. Pan R.D. Ye S. Huang The G(12/13)-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration Oncogene 2005
7. A.E. Carpenter T.R. Jones M.R. Lamprecht C. Clarke I.H. Kang O. Friman D.A. Guertin J.H. Chang R.A. Lindquist J. Moffat P. Golland D.M. Sabatini CellProfiler: image analysis software for identifying and quantifying cell phenotypes Genome Biology 7 10 2006 R100
8. L.C. Chan W. Peters Y. Xu J. Chun R.V. Farese Jr. S. Cases LPA3 receptor mediates chemotaxis of immature murine dendritic cells to unsaturated lysophosphatidic acid (LPA) Journal of Leukocyte Biology 82 5 2007 1193 1200
9. M. Chen L.N. Towers K.L. O'Connor LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells American Journal of Physiology 292 5 2007 C1927 C1933
10. S. Chettibi A.J. Lawrence R.D. Stevenson J.D. Young Effect of lysophosphatidic acid on motility, polarisation and metabolic burst of human neutrophils FEMS Immunology and Medical Microbiology 8 3 1994 271 281
11. K. Chitaley L. Chen A. Galler U. Walter G. Daum A.W. Clowes Vasodilator-stimulated phosphoprotein is a substrate for protein kinase C FEBS Letters 556 1–3 2004 211 215
12. L. Dertsiz G. Ozbilim Y. Kayisli G.A. Gokhan A. Demircan U.A. Kayisli Differential expression of VASP in normal lung tissue and lung adenocarcinomas Thorax 60 7 2005 576 581
13. A.M. Eder T. Sasagawa M. Mao J. Aoki G.B. Mills Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2 Clinical Cancer Research 6 6 2000 2482 2491
14. J.R. Erickson Y. Hasegawa X. Fang A. Eder M. Mao T. Furui J. Aoki A. Morris G.B. Mills Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management Prostaglandins 64 1–4 2001 63 81
15. X. Fang D. Gaudette T. Furui M. Mao V. Estrella A. Eder T. Pustilnik T. Sasagawa R. Lapushin S. Yu R.B. Jaffe J.R. Wiener J.R. Erickson G.B. Mills Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer Annals of the New York Academy of Sciences 905 2000 188 208
16. X. Fang M. Schummer M. Mao S. Yu F.H. Tabassam R. Swaby Y. Hasegawa J.L. Tanyi R. LaPushin A. Eder R. Jaffe J. Erickson G.B. Mills Lysophosphatidic acid is a bioactive mediator in ovarian cancer Biochimica et Biophysica Acta 1582 1–3 2002 257 264
17. X. Fang S. Yu R.C. Bast S. Liu H.J. Xu S.X. Hu R. LaPushin F.X. Claret B.B. Aggarwal Y. Lu G.B. Mills Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells The Journal of Biological Chemistry 279 10 2004 9653 9661
18. T. Fujita S. Miyamoto I. Onoyama K. Sonoda E. Mekada H. Nakano Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer Cancer Letters 192 2 2003 161 169
19. N.S. Gov A. Gopinathan Dynamics of membranes driven by actin polymerization Biophysical Journal 90 2 2006 454 469
20. K. Hama J. Aoki M. Fukaya Y. Kishi T. Sakai R. Suzuki H. Ohta T. Yamori M. Watanabe J. Chun H. Arai Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1 The Journal of Biological Chemistry 279 17 2004 17634 17639
21. F. Hao M. Tan X. Xu J. Han D.D. Miller G. Tigyi M.Z. Cui Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha Biochimica et Biophysica Acta 1771 7 2007 883 892
22. Y. Hasegawa J.R. Erickson G.J. Goddard S. Yu S. Liu K.W. Cheng A. Eder K. Bandoh J. Aoki R. Jarosz A.D. Schrier K.R. Lynch G.B. Mills X. Fang Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor The Journal of Biological Chemistry 278 14 2003 11962 11969
23. A.K. Howe B.P. Hogan R.L. Juliano Regulation of vasodilator-stimulated phosphoprotein phosphorylation and interaction with Abl by protein kinase A and cell adhesion The Journal of Biological Chemistry 277 41 2002 38121 38126
24. T. Iwasaki A. Nakata M. Mukai K. Shinkai H. Yano H. Sabe E. Schaefer M. Tatsuta T. Tsujimura N. Terada E. Kakishita H. Akedo Involvement of phosphorylation of Tyr-31 and Tyr-118 of paxillin in MM1 cancer cell migration International Journal of Cancer 97 3 2002 330 335
25. A. Jemal R. Siegel E. Ward T. Murray J. Xu M.J. Thun Cancer statistics, 2007 CA: A Cancer Journal for Clinicians 57 1 2007 43 66
26. G. Jiang Y. Xu Y. Fujiwara T. Tsukahara R. Tsukahara J. Gajewiak G. Tigyi G.D. Prestwich alpha-Substituted phosphonate analogues of lysophosphatidic acid (LPA) selectively inhibit production and action of LPA ChemMedChem 2 5 2007 679 690
27. K.S. Kim S. Sengupta M. Berk Y.G. Kwak P.F. Escobar J. Belinson S.C. Mok Y. Xu Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo Cancer Research 66 16 2006 7983 7990
28. Y. Kishi S. Okudaira M. Tanaka K. Hama D. Shida J. Kitayama T. Yamori J. Aoki T. Fujimaki H. Arai Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid The Journal of Biological Chemistry 281 25 2006 17492 17500
29. K. Kotarsky A. Boketoft J. Bristulf N.E. Nilsson A. Norberg S. Hansson C. Owman R. Sillard L.M. Leeb-Lundberg B. Olde Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes The Journal of Pharmacology and Experimental Therapeutics 318 2 2006 619 628
30. C.W. Lee R. Rivera S. Gardell A.E. Dubin J. Chun GPR92 as a new G(12/13)- and G(q)-coupled lysophosphatidic acid receptor that increases cAMP, LPA5 The Journal of Biological Chemistry 281 33 2006 23589 23597
31. J.S. Levine J.S. Koh V. Triaca W. Lieberthal Lysophosphatidic acid: a novel growth and survival factor for renal proximal tubular cells The American Journal of Physiology 273 4 Pt 2 1997 F575 F585
32. J. Lu Y.J. Xiao L.M. Baudhuin G. Hong Y. Xu Role of ether-linked lysophosphatidic acids in ovarian cancer cells Journal of Lipid Research 43 3 2002 463 476
33. T.J. Manning Jr. J.C. Parker H. Sontheimer Role of lysophosphatidic acid and rho in glioma cell motility Cell Motility and the Cytoskeleton 45 3 2000 185 199
34. T.M. McIntyre A.V. Pontsler A.R. Silva A. St Hilaire Y. Xu J.C. Hinshaw G.A. Zimmerman K. Hama J. Aoki H. Arai G.D. Prestwich Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist Proceedings of the National Academy of Sciences of the United States of America 100 1 2003 131 136
35. G.B. Mills A. Eder X. Fang Y. Hasegawa M. Mao Y. Lu J. Tanyi F.H. Tabassam J. Wiener R. Lapushin S. Yu J.A. Parrott T. Compton W. Tribley D. Fishman M.S. Stack D. Gaudette R. Jaffe T. Furui J. Aoki J.R. Erickson Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer Cancer Treatment and Research 107 2002 259 283
36. M. Mukai F. Imamura M. Ayaki K. Shinkai T. Iwasaki K. Murakami-Murofushi H. Murofushi S. Kobayashi T. Yamamoto H. Nakamura H. Akedo Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA) International Journal of Cancer 81 6 1999 918 922
37. K. Murakami-Murofushi M. Mukai S. Kobayashi T. Kobayashi G. Tigyi H. Murofushi A novel lipid mediator, cyclic phosphatidic acid (cPA), and its biological functions Annals of the New York Academy of Sciences 905 2000 319 321
38. M. Murph T. Tanaka S. Liu G.B. Mills Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer Clinical Cancer Research 12 22 2006 6598 6602
39. K. Noguchi S. Ishii T. Shimizu Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family The Journal of Biological Chemistry 278 28 2003 25600 25606
40. K.L. O'Connor A.M. Mercurio Protein kinase A regulates Rac and is required for the growth factor-stimulated migration of carcinoma cells The Journal of Biological Chemistry 276 51 2001 47895 47900
41. T.S. Panetti D.F. Mosher Lysophospholipid-induced cell migration Annals of the New York Academy of Sciences 905 2000 326 329
42. S.Y. Park K.A. Schinkmann S. Avraham RAFTK/Pyk2 mediates LPA-induced PC12 cell migration Cellular Signalling 18 7 2006 1063 1071
43. S.M. Pasternack I. von Kugelgen K.A. Aboud Y.A. Lee F. Ruschendorf K. Voss A.M. Hillmer G.J. Molderings T. Franz A. Ramirez P. Nurnberg M.M. Nothen R.C. Betz G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth Nature Genetics 40 3 2008 329 334
44. J. Profirovic M. Gorovoy J. Niu S. Pavlovic T. Voyno-Yasenetskaya A novel mechanism of G protein-dependent phosphorylation of vasodilator-stimulated phosphoprotein The Journal of Biological Chemistry 280 38 2005 32866 32876
45. A.J. Ridley A. Hall Signal transduction pathways regulating Rho-mediated stress fibre formation: requirement for a tyrosine kinase The Embo Journal 13 11 1994 2600 2610
46. K. Rottner B. Behrendt J.V. Small J. Wehland VASP dynamics during lamellipodia protrusion Nature Cell Biology 1 5 1999 321 322
47. K. Sawada K. Morishige M. Tahara R. Kawagishi Y. Ikebuchi K. Tasaka Y. Murata Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho Cancer Research 62 21 2002 6015 6020
48. D. Shida J. Kitayama H. Yamaguchi Y. Okaji N.H. Tsuno T. Watanabe Y. Takuwa H. Nagawa Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1 Cancer Research 63 7 2003 1706 1711
49. M.L. Stracke H.C. Krutzsch E.J. Unsworth A. Arestad V. Cioce E. Schiffmann L.A. Liotta Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein The Journal of Biological Chemistry 267 4 1992 2524 2529
50. K. Tabata K. Baba A. Shiraishi M. Ito N. Fujita The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor Biochemical and Biophysical Research Communications 363 3 2007 861 866
51. G. Tigyi D.J. Fischer A. Sebok F. Marshall D.L. Dyer R. Miledi Lysophosphatidic acid-induced neurite retraction in PC12 cells: neurite-protective effects of cyclic AMP signaling Journal of Neurochemistry 66 2 1996 549 558
52. A. Uchiyama M. Mukai Y. Fujiwara S. Kobayashi N. Kawai H. Murofushi M. Inoue S. Enoki Y. Tanaka T. Niki T. Kobayashi G. Tigyi K. Murakami-Murofushi Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid Biochimica et Biophysica Acta 1771 1 2007 103 112
53. M. Umezu-Goto Y. Kishi A. Taira K. Hama N. Dohmae K. Takio T. Yamori G.B. Mills K. Inoue J. Aoki H. Arai Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production The Journal of Cell Biology 158 2 2002 227 233
54. W.J. Valentine Y. Fujiwara R. Tsukahara G. Tigyi Lysophospholipid signaling: beyond the EDGs Biochimica et Biophysica Acta 2007
55. F.N. Van Leeuwen C. Olivo S. Grivell B.N. Giepmans J.G. Collard W.H. Moolenaar Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1 The Journal of Biological Chemistry 278 1 2003 400 406
56. J. Xu Y.J. Lai W.C. Lin F.T. Lin TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor The Journal of Biological Chemistry 279 11 2004 10459 10468
57. A. Zaslavsky L.S. Singh H. Tan H. Ding Z. Liang Y. Xu Homo- and hetero-dimerization of LPA/S1P receptors, OGR1 and GPR4 Biochimica et Biophysica Acta 1761 10 2006 1200 1212